|
Five new MDS drugs “set to launch by 2018”
PharmaTimes Currently, there is only one curative treatment for MDS – allogeneic hematopoietic stem cell transplant (HSCT); however, because of old age and poor general performance status, around 75% of patients are classified as ineligible for this treatment … |
PennDOT Highlights New Organ Donation Initiative for National Donor Day – Gant Daily
|
PennDOT Highlights New Organ Donation Initiative for National Donor Day
Gant Daily There is no fee to place the organ donor designation on your driver’s license or photo ID. More than 8,300 of the 116,000 Americans awaiting life-saving organ transplants reside in Pennsylvania. However, the number of donors is not keeping pace with … |
Guide: Listing of events – Gainesville Sun
|
Guide: Listing of events
Gainesville Sun TWO-ORGAN SPECTACULAR: Concert features two organs performed by John T. Lowe, Jr., John Bradford Bohl, Timothy Denton and Peter Kinzie, 3 p.m. Sunday, Holy Trinity Episcopal Church, 100 NE First St. Free. … INDIAN INK THEATRE COMPANY — “GURU OF CHAI … |
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger … – SelectScience.net (press release)
|
Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger …
SelectScience.net (press release) Life Technologies Corporation today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. The development represents additional execution against the … |
Michelle Heaton to undergo heart operation – Times of India
 Times of India |
Michelle Heaton to undergo heart operation
Times of India “After the Big Reunion gig, I’m going to have an operation, where they’ll put electrical wires into my heart. It doesn’t sound nice and I’ll be awake… They’ll measure my heartbeat and see where the arrhythmia (irregularity) is coming from,” Heaton … |
Ambulance service 'crippled' by flu peak – Hamilton Spectator
 Hamilton Spectator |
Ambulance service ‘crippled’ by flu peak
Hamilton Spectator Three minutes is a significant jump for critical care, considering brain death can occur in three to four minutes when vital signs are absent. “It crippled our service,” said Mario Posteraro, president of Ontario Public Service Employees Union Local 256. |
US FDA grants "breakthrough" status for Janssen and Pharmacyclics ibrutinib – The Pharma Letter
|
US FDA grants “breakthrough” status for Janssen and Pharmacyclics ibrutinib
The Pharma Letter A Phase III randomized, multi-center registration trial of ibrutinib as a monotherapy versus temsirolimus in relapsed or refractory MCL patients who received at least one prior rituximab-containing chemotherapy regimen, RAY (MCL3001). • A Phase III … |
MorphoSys, Heptares enter pact to develop antibody therapeutics targeting … – pharmabiz.com
|
MorphoSys, Heptares enter pact to develop antibody therapeutics targeting …
pharmabiz.com We believe that by combining Heptares’ unique StaR platform for generating stable GPCRs as antigens with our antibody discovery technology, we will be able to unlock the immense potential of therapeutic antibodies against GPCRs.” Malcolm Weir, chief … |
Doctors urge move to 'opt-out' organ donor system in Scotland – The Courier
 ITV News |
Doctors urge move to ‘opt-out’ organ donor system in Scotland
The Courier The BMA is also urging more Scots to sign up to the Organ Donor Register and to discuss their wishes with friends and family. Ms Hollis said: “It is vital that people talk to their loved ones about their wishes and discuss openly their views on organ … From the Heart: Organ Donation around the WorldITV News Alexandra Burke – Stars Boost Awareness Of Organ Donor Drive With Tv SpecialContactmusic.com New campaign hopes to get people talking about organ donationstv.tv Health24.com –TopNews New Zealand –ParamusPost.com all 17 news articles » |
Theradiag's new biotherapy monitoring kits receive CE mark approval – News-Medical.net
|
Theradiag’s new biotherapy monitoring kits receive CE mark approval
News-Medical.net Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostic and in vitro diagnostics, today announced it has obtained a CE mark for two new biotherapy monitoring kits; Tocilizumab (anti-IL6R) and Rituximab (anti-CD20) that … |